Articles in medical journals from researchers with links to pharmaceuticals
companies show a marked bias towards drugs made by those firms, a survey
suggests.
Henry Stelfox of the University of Toronto and his colleagues looked at
reviews, letters to the editor and other articles on calcium-channel
antagonists, used to treat high blood pressure and prevent heart attacks.
Researchers who supported the use of these drugs were nearly three times as
likely to have 鈥渇inancial relationships鈥� with the drugs鈥� manufacturers as
researchers who did not (The New England Journal of Medicine, vol 338, p
101).
Advertisement